Filing Details

Accession Number:
0001231552-10-000003
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-03-08 12:00:00
Reporting Period:
2010-03-05
Filing Date:
2010-03-08
Accepted Time:
2010-03-08 15:41:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1054833 Coventry Health Care Inc CVH Hospital & Medical Service Plans (6324) 522073000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1231552 Jr C Harvey Demovick 6705 Rockledge Drive
Suite 900
Bethesda MD 20817
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-03-05 175 $0.00 1,005,293 No 4 A Direct
Common Stock Disposition 2010-03-05 919 $0.00 1,004,374 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. Shares of common stock accumulated at various times and at various prices through non-discretionary employer matching contributions under the Company's 401(k) Plan.
  2. See Footnote 1.
  3. Includes the following: Table I-Non-Derivative Securities comprised of 4,374 shares of common stock held directly, 919 shares of common stock held indirectly by managed account (401(k) Plan), 310,345 shares held outright as an award of restricted common stock with restrictions lapsing in equal annual increments over a 3-year period; and Table II-Derivative Securities comprised of a non-qualified stock option representing 689,655 shares of common stock vesting in equal annual increments over a three-year period.
  4. See Footnote 3 for shares held directly and indirectly.
  5. Shares of common stock accumulated through non-discretionary employer matching contributions under the Company's 401(k) Plan.
  6. See Footnote 1.
  7. Includes the following: Table I-Non-Derivative Securities comprised of 4,374 shares of common stock held directly, 310,345 shares held outright as an award of restricted common stock with restrictions lapsing in equal annual increments over a 3-year period; and Table II-Derivative Securities comprised of a non-qualified stock option representing 689,655 shares of common stock vesting in equal annual increments over a three-year period.